BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11270926)

  • 1. Lithium augmentation in venlafaxine-refractory depression.
    Zullino D; Preisig M; Baumann P
    J Clin Psychopharmacol; 2001 Apr; 21(2):242-3. PubMed ID: 11270926
    [No Abstract]   [Full Text] [Related]  

  • 2. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
    Whyte EM; Basinski J; Farhi P; Dew MA; Begley A; Mulsant BH; Reynolds CF
    J Clin Psychiatry; 2004 Dec; 65(12):1634-41. PubMed ID: 15641868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is successful lithium augmentation limited to serotonergic antidepressants?
    Bschor T; Bauer M
    J Clin Psychopharmacol; 2004 Apr; 24(2):240-1; author reply 241-2. PubMed ID: 15206679
    [No Abstract]   [Full Text] [Related]  

  • 4. Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association.
    Liberek C; Aubry JM; Baud P
    Therapie; 2006; 61(6):531-3. PubMed ID: 17348610
    [No Abstract]   [Full Text] [Related]  

  • 5. Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.
    Amsterdam JD; Wang G; Shults J
    Acta Psychiatr Scand; 2010 Mar; 121(3):201-8. PubMed ID: 19694630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression.
    Fountoulakis KN; Iacovides A; St Kaprinis G
    Can J Psychiatry; 2004 Jan; 49(1):73-4. PubMed ID: 14763683
    [No Abstract]   [Full Text] [Related]  

  • 7. S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.
    Alpert JE; Papakostas G; Mischoulon D; Worthington JJ; Petersen T; Mahal Y; Burns A; Bottiglieri T; Nierenberg AA; Fava M
    J Clin Psychopharmacol; 2004 Dec; 24(6):661-4. PubMed ID: 15538131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
    Hsiao MC; Liu CY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):576. PubMed ID: 17889418
    [No Abstract]   [Full Text] [Related]  

  • 9. Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions?
    Jureidini J; Mintzes B
    J Clin Psychiatry; 2008 May; 69(5):865-6; author reply 866. PubMed ID: 18681767
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A
    Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract]   [Full Text] [Related]  

  • 11. Sertraline versus venlafaxine XR in major depressive disorder.
    Lusicic A; Jagadheesan K
    J Clin Psychiatry; 2007 Oct; 68(10):1618-9; author reply 1619. PubMed ID: 17960983
    [No Abstract]   [Full Text] [Related]  

  • 12. Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report.
    Bader GM; Hawley JM; Short DD
    J Clin Psychopharmacol; 1998 Jun; 18(3):255-6. PubMed ID: 9617988
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract]   [Full Text] [Related]  

  • 15. Regarding "Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs".
    Koesters M; Becker T; Weinmann S
    Biol Psychiatry; 2009 Sep; 66(5):e7; authour reply e9-10. PubMed ID: 19520365
    [No Abstract]   [Full Text] [Related]  

  • 16. [Love, humor and psychosis in an atypical depression].
    Sicot R
    Encephale; 2005 Oct; 31 Pt 2():S11-3. PubMed ID: 16673695
    [No Abstract]   [Full Text] [Related]  

  • 17. Venlafaxine and treatment-resistant depression.
    Thase ME; Friedman ES; Howland RH
    Depress Anxiety; 2000; 12 Suppl 1():55-62. PubMed ID: 11098415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.
    Paslakis G; Gilles M; Deuschle M
    J Clin Psychopharmacol; 2010 Aug; 30(4):473-4. PubMed ID: 20631572
    [No Abstract]   [Full Text] [Related]  

  • 19. Venlafaxine: Successful treatment in impulsive disorders.
    Camardese G; Picello A; Bria P
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):241-2. PubMed ID: 18412851
    [No Abstract]   [Full Text] [Related]  

  • 20. The review by Weinmann and colleagues.
    Freemantle N
    Psychopharmacology (Berl); 2008 Jul; 199(1):131-2; author reply 133-4. PubMed ID: 18504557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.